Nov 15, 2021 / 01:00PM GMT
Josh Patterson - Gamida Cell Ltd. - General Counsel
Good morning, everyone. Welcome to today's call during which we will provide an update on the company and review our financial results for the third quarter of 2021. Earlier this morning, we issued a press release summarizing our financial results and progress across the company, which is available on our website at www.gamida-cell.com.
Here with me on our call today are Julian Adams, Chief Executive Officer; Ronit Simantov, our Chief Medical Officer; Michele Korfin, Chief Operating Officer and Chief Commercial Officer; Shai Lankry, Chief Financial Officer; and additionally, Jas Uppal, our Chief Regulatory and Quality Officer, will join for the Q&A session following our prepared remarks.
During this call, we may make forward-looking statements about our future expectations and plans, including in respect of the timing of initiation and progress of and data reported from the clinical trials of our product candidates; anticipated regulatory filings, including the
Q3 2021 Gamida Cell Ltd Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers